Valence8 Us LP Applied Therapeutics Inc. Transaction History
Valence8 Us LP
- $241 Billion
- Q3 2024
A detailed history of Valence8 Us LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Valence8 Us LP holds 20,300 shares of APLT stock, worth $176,407. This represents 0.07% of its overall portfolio holdings.
Number of Shares
20,300Holding current value
$176,407% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$91.6 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$86.1 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$85.4 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$69.6 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$59.1 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $417M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...